Amplimmune, based in Gaithersburg, MD, is a biopharmaceutical company dedicated to transforming the future of healthcare through innovative science. With a focus on precision medicine and transformative technologies, they aim to develop next-generation therapeutics across various therapy areas including oncology, immunology, and rare diseases.
Driven by a commitment to sustainability and ethical practices, Amplimmune collaborates with global partners to advance healthcare solutions for the benefit of individuals, society, and the planet. Their robust R&D pipeline and strategic centers worldwide position them as industry leaders in delivering cutting-edge treatments and driving industry-leading growth.
Generated from the website